ICFG Spain acts as Financial Advisor to Villapharma Research in its divestment to Eurofins Scientific (EUFI:PA)
| Seller | Villapharma |
| Target | Villapharma Research |
| Deal Type | Mergers & Acquisitions |
| Buyer | Eurofins Scientific (EUFI:PA) |
| Territory | Spain |
| Transaction Description | Eurofins Scientific (EUFI.PA) a world leader in providing analytical support to the global pharmaceutical industry, announces the signing of an agreement to acquire Villapharma Research SL (“Villapharma”) in Spain. The transaction is expected to close in February 2017, upon fulfilment of customary closing conditions. Villapharma provides organic synthesis and medicinal chemistry services to global pharmaceutical and biotech companies for the discovery and optimization of potential new drug candidates. Founded in 2003, Villapharma employs 86 staff at its laboratory in Murcia and runs a research outsourcing business model for its clients. The company expects to generate more than EUR 6m of revenues in 2016 with EBITDA margins compatible with Group objective. Villapharma’s offering is complementary to Eurofins’ existing competencies as a leading provider of pharmaceutical discovery services, currently focused primarily on safety pharmacology, ADME and target pathways. The transaction therefore expands the Group’s services into a more comprehensive offering and further strengthens its service proposition for the pharma/biotech industry. |
| Industry Sector | Healthcare |
| ICFG Office | Stuttgart |
ICFG Spain acts as Financial Advisor to Villapharma Research in its divestment to Eurofins Scientific (EUFI:PA)
| Boltendahl International Partners originated the transaction for Villapharma Research and accompained the deal until its successful closing. |
